HOME > COLUMN

COLUMN

Maurer's Healthcare Insight (77)

July 24, 2006
Maurer's Healthcare Insight (76)

June 26, 2006
Maurer's Healthcare Insight (75)

May 29, 2006
Maurer's Healthcare Insight (74)

April 10, 2006
Maurer's Healthcare Insight (73)

March 13, 2006
Maurer's Healthcare Insight (71)

December 19, 2005
Maurer's Healthcare Insight (70)

November 28, 2005
Maurer's Healthcare Insight(69)

November 14, 2005
Maurer's Healthcare Insight (68)

October 17, 2005
Maurer's Healthcare Insight (67)

September 26, 2005
Maurer's Healthcare Insight (66)

August 8, 2005
Maurer's Healthcare Insight (65)

July 11, 2005
Maurer's Healthcare Insight (64)

June 13, 2005
Maurer's Healthcare Insight (63)

May 30, 2005
Maurer's Healthcare Insight (62)

April 25, 2005
Maurer's Healthcare Insight (61)

March 28, 2005
Maurer's Healthcare Insight (60)

March 14, 2005
Maurer's Healthcare Insight (59)

December 6, 2004
Maurer's Healthcare Insight (58)

November 8, 2004
Maurer's Healthcare Insight (57)

October 11, 2004

ページ

Chuikyo Debate on FY2026 Drug Pricing Reform

Chuikyo Backs Draft FY2026 Pricing Reform Outline, Rejects Key Industry Requests

By Takashi Ebisawa

The Ministry of Health, Labor and Welfare (MHLW) on December 12 presented a draft outline of the FY2026 drug pricing…

COLUMN

AI: Your New HR BFF (Not Your Replacement!)

By Philip Carrigan

Let’s ditch the stuffy jargon and talk about AI in HR like real humans.One of the biggest myths floating around is that AI is coming to steal our jobs. Newsflash: that’s not happening. Sure, AI can handle the boring stuff…

COMMENTARY

Radioligand Therapy Faces Capacity Bottleneck in Japan, System Build-Out Needed to Deliver on Promise

By Koji Shimomura

Novartis’ Pluvicto (lutetium vipivotide tetraxetan (177Lu)) won reimbursement listing in Japan in November as a radioligand therapy (RLT) for PSMA-positive…